Bodhi Tree Biotechnology Inc (BDTB) stock

BDTBOTCServices-Management Consulting ServicesFiscal year ends September 30

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026

$0.28+0.00 (0.00%)

Close on Oct 19, 2026Market cap $7.17MP/E –Yield –

Bodhi Tree Biotechnology operating margin

Operating margin is operating income as a percentage of revenue.

Bodhi Tree Biotechnology's operating margin for the twelve months ending Jun 30, 2026 was -310.2%. For fiscal 2025 it was -868.3%.

Period	Period end	Value	Change (pts)
FY2025	Sep 30, 2025	-868.3%	–

Change is against the same quarter a year earlier.

Periods

Period	Period end	Value	Change (pts)
Q3 FY2026CQ2 2026	Jun 30, 2026	-232.0%	−296.8
Q2 FY2026CQ1 2026	Mar 31, 2026	-186.2%	–
Q4 FY2025CQ3 2025	Sep 30, 2025	-89.1%	–
Q1 FY2025CQ4 2024	Dec 31, 2024	-1295.5%	–
Q3 FY2024CQ2 2024	Jun 30, 2024	64.9%	–

Parsed from the XBRL in Bodhi Tree Biotechnology's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BDTB.

Operating margin-310.2% · median -1427.6%

Net margin-313.6% · median -974.4%

Advertisement
300 × 250

See a number that looks wrong?